tipifarnib has been researched along with manumycin in 3 studies
Studies (tipifarnib) | Trials (tipifarnib) | Recent Studies (post-2010) (tipifarnib) | Studies (manumycin) | Trials (manumycin) | Recent Studies (post-2010) (manumycin) |
---|---|---|---|---|---|
309 | 92 | 94 | 159 | 0 | 47 |
Protein | Taxonomy | tipifarnib (IC50) | manumycin (IC50) |
---|---|---|---|
Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus (Norway rat) | 0.81 | |
GTPase KRas | Homo sapiens (human) | 3.58 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Korzeniecki, C; Priefer, R | 1 |
Crovella, S; De Leo, L; Decorti, G; Marcuzzi, A; Pontillo, A; Tommasini, A | 1 |
Fang, H; Gao, P; Jiang, X; Qiao, J | 1 |
1 review(s) available for tipifarnib and manumycin
Article | Year |
---|---|
Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway.
Topics: Humans; Models, Molecular; Molecular Structure; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Signal Transduction | 2021 |
2 other study(ies) available for tipifarnib and manumycin
Article | Year |
---|---|
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency.
Topics: Acyclic Monoterpenes; Alendronate; Animals; Anti-Inflammatory Agents; Cell Line; Child; Child, Preschool; Cholesterol; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Inflammation Mediators; Lovastatin; Male; Mevalonate Kinase Deficiency; Mice; Monocytes; Phosphotransferases (Alcohol Group Acceptor); Piperidines; Polyenes; Polyisoprenyl Phosphates; Polyunsaturated Alkamides; Pyridines; Quinolones; Terpenes | 2011 |
In vitro antifungal activity of farnesyltransferase inhibitors against clinical isolates of Aspergillus and Candida.
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Enzyme Inhibitors; Farnesyltranstransferase; Humans; Microbial Sensitivity Tests; Polyenes; Polyunsaturated Alkamides; Quinolones | 2013 |